These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19623660)

  • 1. Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3.
    Selvendiran K; Bratasz A; Kuppusamy ML; Tazi MF; Rivera BK; Kuppusamy P
    Int J Cancer; 2009 Nov; 125(9):2198-204. PubMed ID: 19623660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor.
    McCann GA; Naidu S; Rath KS; Bid HK; Tierney BJ; Suarez A; Varadharaj S; Zhang J; Hideg K; Houghton P; Kuppusamy P; Cohn DE; Selvendiran K
    Oncoscience; 2014; 1(3):216-28. PubMed ID: 25594014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma.
    Bixel K; Saini U; Kumar Bid H; Fowler J; Riley M; Wanner R; Deepa Priya Dorayappan K; Rajendran S; Konishi I; Matsumura N; Cohn DE; Selvendiran K
    Int J Cancer; 2017 Nov; 141(9):1856-1866. PubMed ID: 28646535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells.
    Han Z; Feng J; Hong Z; Chen L; Li W; Liao S; Wang X; Ji T; Wang S; Ma D; Chen G; Gao Q
    Biochem Biophys Res Commun; 2013 May; 435(2):188-94. PubMed ID: 23665025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygenation inhibits ovarian tumor growth by downregulating STAT3 and cyclin-D1 expressions.
    Selvendiran K; Kuppusamy ML; Ahmed S; Bratasz A; Meenakshisundaram G; Rivera BK; Khan M; Kuppusamy P
    Cancer Biol Ther; 2010 Aug; 10(4):386-90. PubMed ID: 20562529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
    Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
    Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer.
    Sheng WJ; Jiang H; Wu DL; Zheng JH
    Braz J Med Biol Res; 2013 Aug; 46(8):650-8. PubMed ID: 23969971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
    Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
    Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
    Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
    Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins.
    Dorayappan KDP; Wanner R; Wallbillich JJ; Saini U; Zingarelli R; Suarez AA; Cohn DE; Selvendiran K
    Oncogene; 2018 Jul; 37(28):3806-3821. PubMed ID: 29636548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy.
    Meng J; Liu K; Shao Y; Feng X; Ji Z; Chang B; Wang Y; Xu L; Yang G
    Cell Death Dis; 2020 Feb; 11(2):137. PubMed ID: 32080166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.
    Han Z; Hong Z; Gao Q; Chen C; Hao Z; Ji T; Hu W; Yan Y; Feng J; Liao S; Wu P; Wang D; Wang S; Zhou J; Ma D
    Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor.
    Tierney BJ; McCann GA; Naidu S; Rath KS; Saini U; Wanner R; Kuppusamy P; Suarez A; Goodfellow PJ; Cohn DE; Selvendiran K
    Gynecol Oncol; 2014 Oct; 135(1):133-41. PubMed ID: 25038288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis.
    Kim JS; Shin MJ; Lee SY; Kim DK; Choi KU; Suh DS; Kim D; Kim JH
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear expression of pSTAT3
    Marginean FE; Hellsten R; Krzyzanowska A; Bjartell A
    Pathol Res Pract; 2022 Apr; 232():153811. PubMed ID: 35259550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.
    Escalona RM; Bilandzic M; Western P; Kadife E; Kannourakis G; Findlay JK; Ahmed N
    BMC Cancer; 2020 Oct; 20(1):960. PubMed ID: 33023532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells.
    Zhang R; Chen X; Fu S; Xu L; Lin J
    Oncol Rep; 2020 Sep; 44(3):1224-1232. PubMed ID: 32705214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
    Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
    Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs.
    Butturini E; Carcereri de Prati A; Chiavegato G; Rigo A; Cavalieri E; Darra E; Mariotto S
    Free Radic Biol Med; 2013 Dec; 65():1322-1330. PubMed ID: 24095958
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Saini U; Suarez AA; Naidu S; Wallbillich JJ; Bixel K; Wanner RA; Bice J; Kladney RD; Lester J; Karlan BY; Goodfellow PJ; Cohn DE; Selvendiran K
    Cancer Res; 2018 Apr; 78(7):1739-1750. PubMed ID: 29339537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.